AI assistant
RUA LIFE SCIENCES PLC AGM Information 2024
7892_agm-r_2024-08-28_129ad1ab-0dc7-4452-80a4-fd942eaa7947.html
AGM Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 8926B
RUA Life Sciences PLC
28 August 2024
28 August 2024
RUA Life Sciences plc
("RUA" the "Company" or the "Group")
Result of AGM
RUA Life Sciences plc (AIM:RUA.L), the holding company of a group of medical device businesses focussed on the exploitation of the world's leading long-term implantable biostable polymer (Elast-Eon ™), announces that all resolutions put forward to its Annual General Meeting held yesterday were duly passed and the votes cast were as follows:
| Res No. | Votes For | % | Votes Against | % | Votes Withheld |
| 01 | 6,051,300 | 99.37% | 38,570 | 0.63% | 0 |
| 02 | 6,050,279 | 99.36% | 38,783 | 0.64% | 808 |
| 03 | 6,051,300 | 99.37% | 38,570 | 0.63% | 0 |
| 04 | 6,045,927 | 99.28% | 43,943 | 0.72% | 0 |
| 05 | 6,045,698 | 99.27% | 44,172 | 0.73% | 0 |
| 06 | 5,941,757 | 97.57% | 148,113 | 2.43% | 0 |
| 07 | 5,941,757 | 97.57% | 148,113 | 2.43% | 0 |
The full text of each of the resolutions is set out in the notice of Annual General Meeting, copies of which are available on the Company's website ( www.rualifesciences.com ).
For further information contact:
| RUA Life Sciences | Tel: +44 (0)1294 317073 |
| Bill Brown, CEO | |
| Lachlan Smith, CFO | |
| Cavendish Capital Markets Limited | |
| (Nominated Adviser and Broker) | Tel: +44 (0)20 7220 0500 |
| Giles Balleny/Dan Hodkinson (Corporate Finance) | |
| Charlie Combe (Broking) | |
| Michael Johnson (Sales) |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RAGPRMPTMTTTBAI